ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two Capital Markets events focused on progress and developments in the Company’s Research & Development portfolio today, Thursday 9 November 2023.
No new material information will be disclosed at the events.
ECO Animal Health Group plc researches, develops and commercialises products for livestock.
ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced the disposal of ECOmectin® Horsepaste to ACME Drugs S.r.l in Italy,
ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced an update on trading and business progress for the year ending
ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with
ECO Animal Health Group plc (LON:EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, has announced that the ECOVAXXIN® trademark has been approved by the European
ECO Animal Health Group plc (LON:EAH) has announced that on 5 January 2024 the Company completed the sale of its freehold property in New Malden, Surrey. This was the former registered office of the Company and following
ECO Animal Health Group plc (LON:EAH) has announced that on 21 December 2023 deferred nominal cost share options were granted under the Company’s Deferred Bonus Plan (“DBS”) over 44,562 ordinary shares in the Company (representing approximately 0.07
ECO Animal Health Group plc (LON:EAH) has announced its results for the six months ended 30 September 2023. HIGHLIGHTS Financial · Group Revenue increased 9% to £38.0 million (H1 2022: £34.9 million) o Revenues on a constant currency basis
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will be hosting a Capital Markets Day presentation for retail investors focusing on progress
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has received a new US and Canadian label claim indication for Aivlosin® Water
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it has achieved an A-rating for its ESG activities from Integrum ESG, who
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that the Company is today posting to shareholders notice of the Company’s Annual
ECO Animal Health’s David Hallas discusses a strong set of results, growth drivers, product markets and optimism for the year ahead in this exclusive interview with DirectorsTalk.
ECO Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk to discuss results for the year ended 31st March 2023. David talks us through the highlights, explains what was behind the growth in revenues, profitability and
ECO Animal Health Group plc (LON:EAH) have today provided final results for the year ended 31 March 2023. HIGHLIGHTS Financial · Revenue and adjusted EBITDA ahead of market expectations · Group sales increased by 4% to £85.3m, driven primarily
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, will issue its results for the year ended 31 March 2023 on Monday 10 July
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has provided an update to its expected results for the year ended 31 March
ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be participating at the Animal Health, Nutrition and Technology Innovation
Eco Animal Health Group plc (LON:EAH) CEO David Hallas joins DirectorsTalk Interviews to discuss interim results for the six months ended 20th September. David talks us through the highlights, improved Chinese pork prices, excitement over new product
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.